Hagen Heidi
- SEC CIK
- 0001585084
In the past year, 1 open-market sale filing worth $486.1K and no purchases.
Current role at each company
- OBX Obsidian Therapeutics, Inc.Directoras of Aug 5, 2026
- VCEL Vericel CorpDirectoras of May 1, 2026
- TCRT Alaunos Therapeutics, Inc.Directoras of Sep 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $486.1K
- 1 filing
- Net
- −$486.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hagen Heidi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VCEL Vericel Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 (view filing) | Mar 23 | 2 days | Hagen HeidiDirector | SSale | −15.0K | $32.41 | −$486.1K | −32.0%31.9K after | 10b5-1 |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Hagen HeidiDirector | SSale | −9.00K | $49.53 | −$445.8K | −23.9%28.6K after | 10b5-1 |
TCRT Alaunos Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Hagen HeidiDirector | PPurchase | +23.8K | $1.76 | +$41.8K | +19.5%145.9K after |